The novel GLP ‐1/GIP analogue DA5‐CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD
ConclusionTherefore, our results demonstrate that DA5 ‐CH has neuroprotective effects in the STZ‐induced animal model and that DA5‐CH has potential to treat neurodegenerative disorders such as AD.
Source: Brain and Behavior - Category: Neurology Authors: Cheng Li,
Weizhen Liu,
Xiaohui Li,
Zijuan Zhang,
Huaxin Qi,
Shijin Liu,
Ningning Yan,
Ying Xing,
Christian H ölscher,
Zhiju Wang Tags: ORIGINAL RESEARCH Source Type: research
More News: Brain | Diabetes | Diabetes Type 2 | Endocrinology | Hormones | Incretin Therapy | Insulin | Mitochondrial Disease | Neurology | Study